Abstract
The 20th century witnessed the scourge of lung cancer as the disease rapidly rose the ranks to become the commonest cause of cancer mortality in the world. Epidemiological evidence conclusively associated cigarette smoking with the causation of lung cancer in the 1950s. Since then and the few decades after, lung cancer of the squamous cell or small cell histological subtypes was mainly diagnosed among male smokers in developed countries. As we move into the 21st century, the incidence of lung cancer is unlikely to abate but the burden will shift from the developed to the less-developed countries. Other epi-demiological changes of lung cancer include the narrowing of the gap between men and women affected by the disease, predominance of the adenocarcinoma histological subtypes as well as more never-smokers afflicted with the disease. Unless we eliminate tobacco smoking completely, lung cancer will continue its wrath into the 21st century.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Parkin DM, Bray F, Ferlay J, Pisanin P. (2005) Global cancer statistics, 2002. CA Cancer J Clin. 55, 74–108.
Doll R, Hill AB. (1950) Smoking and carcinoma of the lung; preliminary report. Br Med J. 2, 739–748.
Wynder EL, Graham EA. (1950) Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. JAMA. 143, 329–336.
US Department of Health Education, and Welfare (DHEW). (1964) Smoking and health: a report of the Advisory Committee to the Surgeon General of the Public Health Service. DHEW-Public Health Service Publication No. 1103. Washington, DC: US Government Printing Office.
Royal College of Physicians of London. (1962) Smoking and health: summary of a report of the Royal College of Physicians of London on smoking in relation to cancer of the lung and other disease. Publication No. S2–70. Pitman Medical Publishing, LTD, London, UK.
US Department of Health and Human Services (US-DHHS). (1980) The health consequences of smoking for women: a report of the Surgeon General. US-DHHS, Public Health Service, Office of the Assistant Secretary for Health, Office of Smoking and Health.
Devasa SS, Shaw GL, Blot WJ. (1991) Changing patterns of lung cancer incidence by histological type. Cancer Epidemiol Biomarkers Prev 1, 29–34.
Toh CK, Gao F, Lim WT, Leong SS, Fong KW, Yap SP, Hsu AA, Eng P, Koong HN, Thiruganam A, Tan EH. (2006) Never-smokers with lung cancer: epidemiologic evidence of a distinct disease entity. J Clin Oncol. 24, 2245–2251.
US Department of Health and Human Services (US-DHHS). (2001) Women and smoking: a report of the Surgeon General. US-DHHS, Public Health Service, Office of the Surgeon General.
Center for Disease Control and Prevention. (2002) Trends in cigarette smoking among high school students—United States, 1991–2001. Morb Mortal Wkly Rep. 51, 409–412.
Center for Disease Control and Prevention. (2003) Tobacco use among middle and high school students–United States, 2002. Morb Mortal Wkly Rep. 52, 1096–1098.
Warren CW, Jones NR, Eriksen MP, Asma S, for the Global Tobacco Surveillance System (GTSS) Collaborative Group. (2006) Patterns of global tobacco use in young people and implications for future chronic disease burden in adults. Lancet. 367, 749–753.
Husten CG, Shelton DM, Chrismon JH, Lin YC, Mower P, Powell FA. (1997) Cigarette smoking and smoking cessation among older adults: United States, 1965–94. Tob Control. 6, 175–180.
Sorensen G, Pechacek TF. (1987) Attitudes toward smoking cessation among men and women. J Behav Med. 10, 129–137.
McDuffie HH, Klaassen DJ, Dosman JA. (1987) Female-male differences in patients with primary lung cancer. Cancer. 59, 1825–1830.
Brownson RC, Chang JC, Davis JR. (1992) Gender and histologic type variations in smoking-related risk of lung cancer. Epidemiology. 3, 61–64.
Risch HA, Howe GR, Jain M, Burch JD, Holowaty EJ, Miller AB. (1993) Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by his-tologic type. Am J Epidemiol. 138, 281–293.
Harris RE, Zang EA, Anderson JI, Wynder EL. (1993) Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol. 22, 592–599.
Zang EA, Wynder EL. (1996) Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst. 88, 183–192.
International Early Lung Cancer Action Program Investigators. (2006) Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA. 296, 180–184.
Prescott E, Osler M, Hein HO, Borch-Johnsen K, Lange P, Schnohr P, Vestbo J. (1998) Gender and smoking-related risk of lung cancer. The Copenhagen Center for Prospective Population Studies. Epidemiology. 9, 79–83.
Bain C, Feskanich D, Speizer FE, Thun M, Hertzmark E, Rosner BA, Colditz GA. (2004) Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst. 96, 826–834.
Taioli E, Wynder EL. (1994) Re: Endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst. 86, 869–870.
Gao YT, Blot WJ, Zheng W, Ershow AG, Hsu CW, Levin LI, Zhang R, Fraumeni JF Jr. (1987) Lung cancer among Chinese women. Int J Cancer. 40, 604–609.
Seow A, Poh WT, Teh M, Eng P, Wang YT, Tan WC, Chia KS, Yu MC, Lee HP. (2002) Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: evidence for a protective effect of soy in nonsmokers. Int J Cancer. 97, 365–371.
Mollerup S, Berge G, Baera R, Skaug V, Hewer A, Phillips DH, Stangeland L, Hau-gen A. (2004) Sex differences in risk of lung cancer: expression of genes in the PAH bio-activation pathway in relation to smoking and bulky DNA adducts. Int J Cancer. 119, 741–744.
Dresler CM, Fratelli C, Babb J, Everley L, Evans AA, Clapper ML. (2000) Gender differences in genetic susceptibility for lung cancer. Lung Cancer. 30, 153–160.
Shigematsu H, Lin L, Takahashi T, Nomura M, Suzuki M, Wistuba II, Fong KM, Lee H, Toyooka S, Shimizu N, Fujisawa T, Feng Z, Roth JA, Herz J, Minna JD, Gazdar AF. (2005) Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst. 97, 339–346.
Tokumo M, Toyooka S, Kiura K, Shige-matsu H, Tomii K, Aoe M, Ichimura K, Tsuda T, Yano M, Tsukuda K, Tabata M, Ueoka H, Tanimoto M, Date H, Gazdar AF, Shimizu N. (2005) The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small-cell lung cancers. Clin Cancer Res. 11, 1167–1173.
Enstrom JE. (1979) Rising lung cancer mortality among nonsmokers. J Natl Cancer Inst. 62, 755–760.
Boffetta P, Jarvholm B, Brennan P, Nyren O. (2001) Incidence of lung cancer in a large cohort of non-smoking men from Sweden. Int J Cancer. 94, 591–593.
Thun MJ, Henly SJ, Burns D, Jemal A, Shanks TG, Calle EE. (2006) Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst. 98:691–699.
Forastiere F, Perucci CA, Arca M, Axelson O. (1993) Indirect estimates of lung cancer death rates in Italy not attributable to active smoking. Epidemiology. 4, 502–510.
Sridhar KS, Raub WA Jr. (1992) Present and past smoking history and other predisposing factors in 100 lung cancer patients. Chest. 101, 19–25.
Zell JA, Ou SH, Ziogas A, Anton-Culver H. (2005) Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors. J Clin Oncol. 23, 8396–8405.
Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. (2000) Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 321, 323–329.
Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, Clarke CA, Holmberg L, Yong LC, Kolonel LN, Gould MK, West DW. (2007) Lung cancer incidence in never smokers. J Clin Oncol. 25, 472–478.
Toh CK, Lim WT. (2007) Lung cancer in never smokers. J Clin Path. 60, 337–340.
Koo LC, Ho JH. (1990) Worldwide epide-miological patterns of lung cancer in non-smokers. Int J Epidemiol. 19 (Suppl 1), S14–23.
Chen CJ, Wu HY, Chuang YC, Chang AS, Luh KT, Chao HH, Chen KY, Chen SG, Lai GM, Huang HH. (1990) Epidemiologic characteristics and multiple risk factors of lung cancer in Taiwan. Anticancer Res. 10, 971–976.
Nordquist LT, Simon GR, Cantor A, Alberts WM, Bepler G. (2004) Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest. 126, 347–351.
Tsao AS, Liu D, Lee JJ, Spitz M, Hong WK. (2006) Smoking affects treatment outcome in patient with advanced nonsmall cell lung cancer. Cancer. 106, 2428–2436.
Suzuki H, Takahashi T, Kuroishi T, Suyama M, Ariyoshi Y, Takahashi T, Ueda R. (1992) p53 mutations in non-small cell lung cancer in Japan: association between mutations and smoking. Cancer Res. 52, 734–736.
Powell CA, Spira A, Derti A, DeLisi C, Liu G, Borczuk A, Busch S, Sahasrabudhe S, Chen Y, Sugarbaker D, Bueno R, Richards WG, Brody JS. (2003) Gene expression in lung adenocarcinomas of smokers and non-smokers. Am J Respir Cell Mol Biol. 29, 157–162.
Toyooka S, Tokumo M, Shigematsu H, Matsuo K, Asano H, Tomii K, Ichihara S, Suzuki M, Aoe M, Date H, Gazdar AF, Shimizu N. (2006) Mutational and epige-netic evidence for independent pathways for lung adenocarcinoma arising in smokers and never smokers. Cancer Res. 66, 1371–1375.
Bromen K, Pohlabeln H, Jahn I, Ahrens W, Jockel KH. (2000) Aggregation of lung cancer in families: results from a population-based case-control study in Germany. Am J Epidemiol. 152, 497–505.
Schwartz AG, Rothrock M, Yang P. (1999) Increased cancer risk among relatives of nonsmoking lung cancer cases. Genet Epidemiol. 17, 1–15.
Gorlova OY, Zhang Y, Schabath MB, Lei L, Zhang Q, Amos CI, Spitz MR. (2006) Never smoker and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer. 118, 1798–1804.
Cheng YW, Chiou HL, Sheu GT, Hsieh LL, Chen JT, Chen CY, Su JM, Lee H. (2001) The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res. 61, 2799–2803.
Ko YC, Cheng LS, Lee CH, Huang JJ, Huang MS, Kao EL, Wang HZ, Lin HJ. (2000) Chinese food cooking and lung cancer in women nonsmokers. Am J Epidemiol. 151, 140–147.
Brennan P, Butler J, Agudo A, Benhamou S, Darby S, Fortes C, Jockel KH, Kreuzer M, Nyberg F, Pohlabeln H, Saracci R, Wich-man HE, Boffetta P. (2000) Joint effect of diet and environmental tobacco smoke on risk of lung cancer among nonsmokers. J Natl Cancer Inst. 92, 426–427.
Vincent RG, Pickren JW, Lane WW, Bross I, Takita H, Houten L, Gutierrez AC, Rzepka T. (1977) The changing histopathology of lung cancer: a review of 1682 cases. Cancer. 39, 1647–1655.
Valaitis J, Warren S, Gamble D. (1981) Increasing incidence of adenocarcinoma of the lung. Cancer. 47, 1042–1046.
Dodds L, Davis S, Polissar L. (1986) A population-based study of lung cancer incidence trends by histologic type, 1974–81. J Natl Cancer Inst. 76, 21–29.
Travis WD, Travis LB, Devesa SS. (1995). Lung Cancer. Cancer. 75 (1 Supp), 191–202.
Ikeda T, Kurita Y, Inutsuka S, Tanaka K, Nakanishi Y, Shigematsu N, Nobutomo K. (1991) The changing pattern of lung cancer by histological type–a review of 1151 cases from a university hospital in Japan, 1970–1989. Lung Cancer. 7, 157–164.
Janssen-Heijnen ML, Nab HW, van Reek J, van der Heijden LH, Schipper R, Coebergh JW. (1995) Striking changes in smoking behaviour and lung cancer incidence by histological type in south-east Netherlands, 1960–1991. Eur J Cancer. 31A, 949–952.
McFarlane MJ, Feinstein AR, Wells CK. (1986) Clinical features of lung cancer discovered as a postmortem “ surprise. ” Chest. 90, 520–523.
Wells CK, Feinstein AR. (1988) Detection bias in the diagnostic pursuit of lung cancer. Am J Epidemiol. 128, 1016–1026.
Kung IT, So KF, Lam TH. (1984) Lung cancer in Hong Kong Chinese: mortality and histological types, 1973–1982. Br J Cancer. 50, 381–388.
Thun MJ, Lally CA, Flannery JT, Calle EE, Dana Flanders W, Health CW Jr. (1997) Cigarette smoking and changes in the his-topathology of lung cancer. J Natl Cancer Inst. 89, 1580–1586.
Wynder El, Graham EA, Croninger AB. (1953) Experimental production of carcinoma with cigarette tar. Cancer Res. 13, 855–864.
Fischer S, Spiegelhalder B, Preussmann R. (1989) Influence of smoking parameters on the delivery of tobacco-specific nitrosamines in cigarette smoke—a contribution to relative risk evaluation. Carcinogenesis. 10, 1059–1066.
Hecht SS. (1997) Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 89, 1580–1586.
Djordjevic MV, Hoffmann D, Hoffmann I. (1997) Nicotine regulates smoking patterns. Prev Med. 26, 435–440.
Kabat KC. (2003) Fifty years' experience of reduced-tar cigarettes: what do we know about their health effects? Inhal Toxicol. 15, 1059–1102.
Harris JE, Thun MJ, Mondul AM, Calle EE. (2004) Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982–8. BMJ. 328, 72.
Parkin DM, Pisani P, Ferlay J. (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 80, 827–841.
Pisani P, Parkin DM, Bray F, Ferlay J. (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 83, 18–29.
Yang G, Fan L, Tan J, Qi G, Zhang Y, Samet JM, Taylor CE, Becker K, Xu J. (1999) Smoking in China: findings of the 1996 National Prevalence Survey. JAMA. 282, 1247–1253.
Wright AA, Katz IT. (2007) Tobacco tightrope–balancing disease prevention and economic development in China. N Engl J Med. 356, 1493–1496.
Liu BQ, Peto R, Chen ZM, Boreham J, Wu YP, Li JY, Colin Campbell T, Chen JS. (1998) Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ. 317, 1411–1422.
Wingo PA, Ries LAG, Giovino GA, Miller DS, Rosenberg HM, Shopland DR, Thun MJ, Edwards BK. (1999) Annual report to the nation on the status of cancer, 1973–1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst. 91, 675–690.
Hoffmann D, Hoffmann I, El-Bayoumy K. The less harmful cigarette: a controversial issue. A tribute to Ernst L. Wynder. (2001) Chem Res Toxicol. 14, 767–790.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Toh, CK. (2009). The Changing Epidemiology of Lung Cancer. In: Verma, M. (eds) Cancer Epidemiology. Methods in Molecular Biology, vol 472. Humana Press. https://doi.org/10.1007/978-1-60327-492-0_19
Download citation
DOI: https://doi.org/10.1007/978-1-60327-492-0_19
Publisher Name: Humana Press
Print ISBN: 978-1-60327-491-3
Online ISBN: 978-1-60327-492-0
eBook Packages: Springer Protocols